Parkinson’s Disease
145 results.
Finding new treatments for Parkinson’s disease is at the heart of the Institute’s mission. Between seven and 10 million people worldwide have the disease, making…
A major clue to understanding Parkinson’s and other neurodegenerative diseases may be right in front of our faces. Or rather, on our faces. At…
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…
By: Patrik Brundin, M.D., Ph.D. Director of Van Andel Research Institute’s Center for Neurodegenerative Science, chairman of The Cure Parkinson’s Trust’s Linked…
New data published today shows drug preserves critical brain function in laboratory models of Parkinson’s GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally…
A few years ago, Caryl Sortwell, a Michigan State University College of Human Medicine Parkinson's researcher, was asked by Jeff MacKeigan, a…
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…
GRAND RAPIDS, Mich. (Aug. 8, 2016)—They’re two of the biggest mysteries in Parkinson’s disease research—where does the disease start? And how can it be stopped…